Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosisNicoletta Del Papa, Agostino Cortelezzi, Gualtiero I. Colombo et al.|Arthritis & Rheumatism|2004Cited by 169
Bone marrow endothelial progenitors are defective in systemic sclerosisNicoletta Del Papa, Giorgio Lambertenghi‐Deliliers, Michela Cortiana et al.|Arthritis & Rheumatism|2006Cited by 165
Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosisNicoletta Del Papa, Agostino Cortelezzi, Francesco Onida et al.|Bone Marrow Transplantation|2016Cited by 72
Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenonBianca Marasini, Claudio Maioli, Marco Massarotti et al.|Scandinavian Journal of Rheumatology|2004Cited by 67
Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis.Nicoletta Del Papa, Agostino Cortelezzi, Michela Cortiana et al.|PubMed|2008Cited by 47